healthcarenewshubb.com Open in urlscan Pro
195.201.240.102  Public Scan

Form analysis
5 forms found in the DOM

GET https://healthcarenewshubb.com/

<form action="https://healthcarenewshubb.com/" method="get" class="jeg_search_form" target="_top">
  <input name="s" class="jeg_search_input" placeholder="Search..." type="text" value="" autocomplete="off">
  <button aria-label="Search Button" type="submit" class="jeg_search_button btn"><i class="fa fa-search"></i></button>
</form>

---

GET https://healthcarenewshubb.com/

<form action="https://healthcarenewshubb.com/" method="get" class="jeg_search_form" target="_top">
  <input name="s" class="jeg_search_input" placeholder="Search..." type="text" value="" autocomplete="off">
  <button aria-label="Search Button" type="submit" class="jeg_search_button btn"><i class="fa fa-search"></i></button>
</form>

---

GET https://healthcarenewshubb.com/

<form action="https://healthcarenewshubb.com/" method="get" class="jeg_search_form" target="_top">
  <input name="s" class="jeg_search_input" placeholder="Search..." type="text" value="" autocomplete="off">
  <button aria-label="Search Button" type="submit" class="jeg_search_button btn"><i class="fa fa-search"></i></button>
</form>

---

POST /19505/?utm_source=GCN&utm_medium=GCN_Email&utm_campaign=NewsHubbarticle_MangoRx

<form id="wpforms-form-1693" class="wpforms-validate wpforms-form wpforms-ajax-form" data-formid="1693" method="post" enctype="multipart/form-data" action="/19505/?utm_source=GCN&amp;utm_medium=GCN_Email&amp;utm_campaign=NewsHubbarticle_MangoRx"
  data-token="84dada40a9fdda1ec91012c629c45e91" novalidate="novalidate"><noscript class="wpforms-error-noscript">Please enable JavaScript in your browser to complete this form.</noscript>
  <div class="wpforms-field-container">
    <div id="wpforms-1693-field_1-container" class="wpforms-field wpforms-field-name" data-field-id="1"><label class="wpforms-field-label" for="wpforms-1693-field_1">Name <span class="wpforms-required-label">*</span></label>
      <div class="wpforms-field-row wpforms-field-medium">
        <div class="wpforms-field-row-block wpforms-first wpforms-one-half"><input type="text" id="wpforms-1693-field_1" class="wpforms-field-name-first wpforms-field-required" name="wpforms[fields][1][first]" required=""><label
            for="wpforms-1693-field_1" class="wpforms-field-sublabel after ">First</label></div>
        <div class="wpforms-field-row-block wpforms-one-half"><input type="text" id="wpforms-1693-field_1-last" class="wpforms-field-name-last wpforms-field-required" name="wpforms[fields][1][last]" required=""><label for="wpforms-1693-field_1-last"
            class="wpforms-field-sublabel after ">Last</label></div>
      </div>
    </div>
    <div id="wpforms-1693-field_2-container" class="wpforms-field wpforms-field-email" data-field-id="2"><label class="wpforms-field-label" for="wpforms-1693-field_2">Email <span class="wpforms-required-label">*</span></label><input type="email"
        id="wpforms-1693-field_2" class="wpforms-field-medium wpforms-field-required" name="wpforms[fields][2]" required=""></div>
  </div>
  <div class="wpforms-recaptcha-container wpforms-is-hcaptcha">
    <div class="g-recaptcha" data-sitekey="bb8bf8f0-e09b-4664-b7bd-5e60d9902242" data-recaptcha-id="0sv4vwzj4r"><iframe
        src="https://newassets.hcaptcha.com/captcha/v1/76de2dd/static/hcaptcha.html#frame=checkbox&amp;id=0sv4vwzj4r&amp;host=healthcarenewshubb.com&amp;sentry=true&amp;reportapi=https%3A%2F%2Faccounts.hcaptcha.com&amp;recaptchacompat=true&amp;custom=false&amp;hl=en&amp;tplinks=on&amp;sitekey=bb8bf8f0-e09b-4664-b7bd-5e60d9902242&amp;theme=light&amp;origin=https%3A%2F%2Fhealthcarenewshubb.com"
        tabindex="0" frameborder="0" scrolling="no" title="Widget containing checkbox for hCaptcha security challenge" data-hcaptcha-widget-id="0sv4vwzj4r" data-hcaptcha-response=""
        style="width: 303px; height: 78px; overflow: hidden;"></iframe><textarea id="g-recaptcha-response-0sv4vwzj4r" name="g-recaptcha-response" style="display: none;"></textarea><textarea id="h-captcha-response-0sv4vwzj4r" name="h-captcha-response"
        style="display: none;"></textarea></div><input type="text" name="g-recaptcha-hidden" class="wpforms-recaptcha-hidden"
      style="position:absolute!important;clip:rect(0,0,0,0)!important;height:1px!important;width:1px!important;border:0!important;overflow:hidden!important;padding:0!important;margin:0!important;" required="">
  </div>
  <div class="wpforms-submit-container"><input type="hidden" name="wpforms[id]" value="1693"><input type="hidden" name="wpforms[author]" value="1"><input type="hidden" name="wpforms[post_id]" value="19505"><button type="submit" name="wpforms[submit]"
      id="wpforms-submit-1693" class="wpforms-submit" data-alt-text="Sending..." data-submit-text="Subscribe Now " aria-live="assertive" value="wpforms-submit">Subscribe Now </button><img
      src="https://healthcarenewshubb.com/wp-content/plugins/wpforms-lite/assets/images/submit-spin.svg" class="wpforms-submit-spinner" style="display: none;" width="26" height="26" alt="" data-pin-no-hover="true"></div>
</form>

---

GET https://healthcarenewshubb.com/

<form action="https://healthcarenewshubb.com/" method="get" class="jeg_search_form" target="_top">
  <input name="s" class="jeg_search_input" placeholder="Search..." type="text" value="" autocomplete="off">
  <button aria-label="Search Button" type="submit" class="jeg_search_button btn"><i class="fa fa-search"></i></button>
</form>

---

Text Content

 * Home
 * Health Care
 * Public Health
 * Men’s Health
 * Women’s Health
 * Children’s Health
 * Health Insurance
 * Contact


No Result
View All Result
 * Home
 * Health Care
 * Public Health
 * Men’s Health
 * Women’s Health
 * Children’s Health
 * Health Insurance
 * Contact


No Result
View All Result
No Result
View All Result

Home Men's Health


ERECTILE DYSFUNCTION SWELLS AS GROWTH MARKET FOR INVESTORS (PFE, MGRX, LLY,
CELZ, HIMS, TEVA, BAYRY)

by healthcare
May 16, 2023
in Men's Health




May 12, 2023 (WallStreetPR via Comtex) — The erectile dysfunction market is
expected to grow at a CAGR of 7.1% from 2021 to 2028. The growth of the market
is attributed to the increasing prevalence of erectile dysfunction, rising
awareness about the condition, and the availability of effective treatments.

Erectile dysfunction is a common condition that affects men of all ages. It is
estimated that approximately 30% of men between the ages of 40 and 70 years old
experience erectile dysfunction. The condition is caused by a variety of
factors, including age, smoking, diabetes, heart disease, and obesity.

The increasing prevalence of erectile dysfunction is a major driver of the
market. The global population is aging, and the number of men with erectile
dysfunction is expected to increase as a result. Additionally, rising awareness
about the condition is leading more men to seek treatment.

The availability of effective treatments is another major driver of the market.
There are a number of FDA-approved medications available for the treatment of
erectile dysfunction, including sildenafil (Viagra), tadalafil (Cialis), and
vardenafil (Levitra). These medications are effective in the majority of men,
and they have a low risk of side effects.

The erectile dysfunction market is expected to continue to grow in the coming
years. The increasing prevalence of the condition, rising awareness, and the
availability of effective treatments are all expected to contribute to the
growth of the market.

Additional factors that are expected to drive the growth of the erectile
dysfunction market include the aging population, the rising prevalence of
chronic diseases, the growing awareness of erectile dysfunction, and the
development of new treatments.

The erectile dysfunction market is a large and growing market. The market is
expected to continue to grow in the coming years due to a number of factors,
including the increasing prevalence of the condition, rising awareness, and the
availability of effective treatments.

With that in mind, we take a look below at some of the most interesting names in
the ED space.

Pfizer Inc. (NYSE: PFE) is a research-based global biopharmaceutical company. It
engages in the discovery, development, manufacture, marketing, sales and
distribution of biopharmaceutical products worldwide.

The firm works across developed and emerging markets to advance wellness,
prevention, treatments and cures that challenge the most feared diseases.

Pfizer Inc. (NYSE: PFE) recently reported financial results for the first
quarter of 2023 and reaffirmed full-year 2023 financial guidance, including
first-quarter 2023 revenues of $18.3 Billion, first-quarter 2023 diluted EPS of
$0.97, a Year-Over-Year Decline of 29%, and Adjusted Diluted EPS(3) of $1.23, a
Year-Over-Year Decline of 24%.

Dr. Albert Bourla, Chairman and Chief Executive Officer, stated: “This is an
exciting time for Pfizer as we are already executing on and rigorously planning
for an unprecedented number of anticipated new product and indication launches,
most of which are expected to occur in the second half of 2023. We have made
excellent progress toward this goal already this year with the U.S. approvals
for Zavzpret, Cibinqo for adolescents and Prevnar 20 in pediatric patients, and
regulatory filing acceptances for a Braftovi + Mektovi sNDA, sNDA for the
Talzenna and Xtandi combination, elranatamab BLA and our RSV maternal vaccine
candidate — which, if approved, would be the first vaccine for administration to
pregnant individuals to help protect against the complications of RSV disease in
infants from birth up to six months of age.”

Even in light of this news, PFE hasn’t really done much of anything over the
past week, with shares logging no net movement over that period.

Pfizer Inc. (NYSE: PFE) managed to rope in revenues totaling $18.3B in overall
sales during the company’s most recently reported quarterly financial data — a
figure that represents a rate of top line growth of -28.8%, as compared to
year-ago data in comparable terms. In addition, the company is battling some
balance sheet hurdles, with cash levels struggling to keep up with current
liabilities.

Mangoceuticals Inc (NASDAQ:MGRX) could very well be the most interesting name on
this list. The stock is cheap, and it uses the same ED biotech as Cialis. But it
has an interesting marketing angle. And, if you hold the tech constant between
two companies, the better marketing angle generally wins.

However, because MGRX has been flying under the radar, it may have a whole lot
of catching up to do.

Mangoceuticals Inc (NASDAQ:MGRX) announced this week the launch of its “Some
Things Are Better Hard” digital marketing campaign. According to the company’s
release, the Campaign leverages a new beautifully produced full-length video
comprised of four individual video shorts, which will be widely distributed,
together as a whole and separately, across multiple social media platforms,
including, but not limited to, Facebook, Instagram, Snapchat, TikTok, YouTube,
Google, and Twitter.

The composition is designed to reinforce the central theme that “Some Things Are
Better Hard”, leveraging humor and an open and confident framing of the pursuit
of male intimate health and personal improvement to defuse social taboos and
normalize ED as a commonly shared functional obstacle to healthy male intimate
experiences.

“This campaign is expected to help to further position Mango in the ED market as
a uniquely accessible resource which has the goal of helping normal men achieve
greater fulfillment and self-confidence while avoiding brand association with
social discomfort,” stated MangoRx Co-Founder and CEO, Jacob Cohen. “We believe
we have opened up a disruptive new lane in this rapidly growing $3.5 billion
market. Peak performance is a good thing. Making your “intimate” life better is
a good thing. Cultural barriers to talking frankly about that pursuit are a bad
thing. Yet, until Mango came along, that’s typically how this marketplace
tacitly operated. We believe that was a blind spot and the Mango brand is
attempting to carve out a new model. We believe that the ‘Some Things Are Better
Hard’ viral digital campaign is a perfect vehicle to press our incipient
branding advantage.”

Mangoceuticals Inc (NASDAQ:MGRX) plans to continue to build its marketing
arsenal to both educate and entertain its audience and target market customer
base. The “Some Things Are Better Hard” digital ad campaign represents the
Company’s second attempt to use creative marketing to widen the branding gap
with its competitors and to be the first ED solution to successfully expand to
include a younger demographic. The Company’s first commercial, which originally
debuted on YouTube in November 2022, has already been viewed nearly 6 million
times.

It’s a very slick ad. You can see it here.

Hims & Hers Health Inc (NYSE: HIMS) bills itself as the leading health and
wellness platform on a mission to help the world feel great through the power of
better health.

According to the company’s materials, “We believe how you feel in your body and
mind transforms how you show up in life. That’s why we’re building a future
where nothing stands in the way of harnessing this power. Hims & Hers normalizes
health & wellness challenges–and innovates on their solutions–to make feeling
happy and healthy easy to achieve. No two people are the same, so the Company
provides access to personalized care designed for results.”

Hims & Hers Health Inc (NYSE: HIMS) recently announced financial results for the
first quarter ended March 31, 2023. “We are pleased with our outstanding
performance in the first quarter, as our ability to deliver more personalized
and accessible products and services is inspiring more customers to take better
care of their health and well-being,” said Andrew Dudum, co-founder and CEO.
“Our significant market opportunity, robust consumer demand and consistent
execution across our four strategic pillars – trusted brand, leading technology,
product innovation and clinical excellence – uniquely positions us as a trusted
market leader.”

“Our resilient customer base and durable recurring revenue model is operating at
a scale that enables us to generate high growth while generating incremental
efficiencies,” said Yemi Okupe, CFO. “These dynamics enable us to unlock our
market opportunity from a position of strength and we expect to continue
delivering leading innovation and access to care to our customers to capitalize
on our growth momentum while driving operational excellence.”

Even in light of this news, HIMS has had a rough past week of trading action,
with shares sinking something like -10% in that time. That said, chart support
is nearby, and we may be in the process of constructing a nice setup for some
movement back the other way.

Hims & Hers Health Inc (NYSE: HIMS) managed to rope in revenues totaling $167.2M
in overall sales during the company’s most recently reported quarterly financial
data — a figure that represents a rate of top line growth of 97.4%, as compared
to year-ago data in comparable terms. In addition, the company has a strong
balance sheet, with cash levels exceeding current liabilities ($179.6M against
$47.9M).

Other key plays in the ED space include Eli Lilly And Co (NYSE: LLY), Creative
Medical Technology Holdings Inc (NASDAQ: CELZ), Teva Pharmaceutical Industries
Ltd (NYSE: TEVA), and Bayer AG (OTCMKTS: BAYRY).

Article Link – Erectile Dysfunction Swells as Growth Market for Investors (PFE,
MGRX, LLY, CELZ, HIMS, TEVA, BAYRY)


Previous Post


ICHRA AFFORDABILITY AND PREMIUM TAX CREDITS

Next Post


UNLEASHING THE FUTURE OF PERSONAL HEALTH: TOP HEALTH AND WELLNESS APPS FOR A
VIBRANT, HOLISTIC LIFESTYLE



Next Post


UNLEASHING THE FUTURE OF PERSONAL HEALTH: TOP HEALTH AND WELLNESS APPS FOR A
VIBRANT, HOLISTIC LIFESTYLE




RECENT POSTS

Men's Health


WHY ARE DUMBBELLS CALLED DUMBBELLS?

by healthcare
May 18, 2023
0

Dumbbells are a popular and effective tool for strength training and exercise.
They’re versatile, easy to use, and come in...

Read more
Women's Health


3 TIPS FOR FINDING A HEALTHCARE PROVIDER WHO SPECIALIZES IN MENOPAUSE

by healthcare
May 18, 2023
0

Every year, more than 1 million people with a uterus in the United States go
through menopause. And, although it’s...

Read more
Children's Health


EASY PIZZA DOUGH RECIPE (NO RISE)

by healthcare
May 18, 2023
0

No time? No problem! This Easy Pizza Dough recipe isn’t only super fast and
insanely easy.. it’s also incredibly delicious!!...

Read more
Health Insurance


ADHD MEDICATION SHORTAGE: 6 WAYS TO COPE

by healthcare
May 18, 2023
0

It seems like every other week there is a new shortage. Toilet paper (doesn’t
that feel like ages ago?), baby...

Read more






© 2023 Healthcare News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless
specified. By using this site, you agree to the Privacy Policy and Terms &
Conditions.




NAVIGATE SITE

 * Home
 * Health Care
 * Public Health
 * Men’s Health
 * Women’s Health
 * Children’s Health
 * Health Insurance
 * Contact


NEWSLETTER SIGN UP.

Please enable JavaScript in your browser to complete this form.
Name *
First
Last
Email *

Subscribe Now



No Result
View All Result
 * Home
 * Health Care
 * Public Health
 * Men’s Health
 * Women’s Health
 * Children’s Health
 * Health Insurance
 * Contact

© 2022 HealthCare News Hubb All rights reserved.